-
COST-EFFECTIVENESS OF ACUPUNCTURE TREATMENT COMPARED TO PLACEBO IN VETERANS WITH COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD)
Feb 25, 2026, 14:41 PM -
EXCESS HEALTHCARE COSTS OF OVERT HEPATIC ENCEPHALOPATHY (OHE) RELATIVE TO NON-OHE CIRRHOSIS IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
NEW FAILURE MODES, OLD STANDARDS: WHY ARTIFICIAL INTELLIGENCE (AI) DEMANDS DIFFERENT VALIDATION APPROACHES IN EVIDENCE SYNTHESIS
Feb 25, 2026, 14:41 PM -
ANALYSIS OF THE EXPENDITURE OF PHARMACEUTICALS PRESCRIBED FOR THE INDICATION OF FEMALE INFERTILITY IN HUNGARY FOR THE PERIOD 2015-2023
Feb 25, 2026, 14:41 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Feb 25, 2026, 14:41 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEEN SOCIAL DETERMINANTS OF HEALTH AND INFLAMMATORY BOWEL DISEASE: A NATIONALLY REPRESENTATIVE ANALYSIS
Feb 25, 2026, 14:41 PM -
A STUDY ON ASSESSMENT OF RISK FACTORS, COMPLICATIONS AND CLINICAL EFFICACY OF HEPATOPROTECTIVES IN LIVER DISEASE
Feb 25, 2026, 14:41 PM -
SHAREHOLDERS AND COMMON OWNERSHIP IN THE MARKET FOR MONOCLONAL ANTIBODIES: A NETWORK ANALYSIS
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL IMPLANT INCORPORATING REAL-WORLD UTILIZATION DATA FROM A LARGE BRAZILIAN PRIVATE HEALTH INSURER
Feb 25, 2026, 14:41 PM -
FUNCTIONAL AND SOCIAL BURDEN OF SPINAL MUSCULAR ATROPHY TYPE 3 IN BRAZIL: A MIXED-METHODS PATIENT-CENTERED STUDY
Feb 25, 2026, 14:41 PM -
GOVERNING RWD- AND GENAI-ENABLED RWE: PRACTICAL, AUDITABLE CONTROLS FOR FASTER—YET TRUSTWORTHY—EVIDENCE GENERATION
Feb 25, 2026, 14:41 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR METABOLIC DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:41 PM -
EXPLORATORY APPLICATION OF BIVARIATE NETWORK META-ANALYSIS TO PREDICT MISSING HAZARD RATIOS IN MCRPC USING SIMULATED CORRELATION DATA
Feb 25, 2026, 14:41 PM -
USING SHORTFALL METRICS TO PRIORITIZE THERAPEUTIC INNOVATION IN ONCOLOGY
Feb 25, 2026, 14:41 PM -
CARDIOMETABOLIC RISK TRAJECTORIES ON AND AFTER ANTI-OBESITY MEDICATION USE: A CLAIMS-BASED ANALYSIS
Feb 25, 2026, 14:41 PM -
COMPARATIVE EVALUATION OF SUBJECTIVE SLEEP QUALITY AND INSOMNIA ACROSS PSYCHIATRIC DISORDERS: EVIDENCE FROM PATIENT-REPORTED OUTCOME MEASURES
Feb 25, 2026, 14:41 PM -
CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Feb 25, 2026, 14:41 PM -
PATIENT-REPORTED SYMPTOM BURDEN, QUALITY OF LIFE AND PRODUCTIVITY IMPACT OF PBC ACROSS FRANCE, ITALY, GERMANY, SPAIN, UNITED KINGDOM, AND THE UNITED STATES OF AMERICA: ANALYSIS OF A REAL-WORLD DATASET
Feb 25, 2026, 14:41 PM -
ESTIMATION METHODS FOR MODELING THE DISTRIBUTION OF MULTI-ATTRIBUTE HEALTH-RELATED QUALITY OF LIFE MEASURES FOR ECONOMIC EVALUATION STUDIES: A CASE STUDY OF THE PROMIS-PROPR
Feb 25, 2026, 14:41 PM
